카바페넴계 항생제 내성균 감염증에 대한 경남권질병대응센터-부산광역시 지자체 합동기획조사-Reference-Cited by-同舟云学术

카바페넴계 항생제 내성균 감염증에 대한 경남권질병대응센터-부산광역시 지자체 합동기획조사

Published:2023-07-20 Issue:28 Volume:16 Page:911-930
ISSN:2005-811X
Container-title:Public Health Weekly Report
language:en
Short-container-title:Public Health Weekly Report

Author:

이 지주¹,장 세혁¹,이 은솔¹,박 경희²,이 현주²,은 영덕²,이 정민³,사공 필용³,김 경아⁴,나 영란⁴,김 연정¹

Affiliation:

1. 질병관리청 경남권질병대응센터 감염병대응과

2. 부산광역시청 감염병관리지원단

3. 부산광역시청 감염병관리과

4. 부산광역시 보건환경연구원 미생물팀

Publisher

Korea Disease Control and Prevention Agency (Public Health Weekly Report)

Link

http://pdf.medrang.co.kr/PHWR/2023/016/PHWR016-28-911.pdf

Reference13 articles.

1. Centers for Disease Control and Prevention (CDC). COVID-19: U.S. Impact on antimicrobial resistance, special report 2022. U.S. Department of Health and Human Services, CDC;2022.

2. Korea Disease Control and Prevention Agency (KDCA). 2022 Guidelines for control of healthcare-associated infection. KDCA;2022.

3. Korea Disease Control and Prevention Agency (KDCA). The 2nd stage of 5-year plan for prevention and control of healthcare-associated infection (2023-2027). KDCA;2023.

4. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, CDC;2019.

5. Jeong H, Hyun J, Lee Y. Antimicrobial resistance and molecular characteristics of Carbapenem-resistant Enterobacteriaceae isolated in the Republic of Korea, 2021. Public Health Wkly Rep 2022;15:2360-3.